Clinical Trial Update: Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase)in Patients With Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update for GRASPA (suspension of erythrocytes encapsulating L-asparaginase) in pancreatic cancer; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• GRASPA (L-asparaginase encapsulated in red blood cells)

Snippet

Sponsor: ERYtech Pharma | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED | Results posted: 2021-10-15